跳到正文

RA Capital Nexus Fund III, L.P. 内部人交易:近期 SEC Form 4 交易

过去 18 个月,RA Capital Nexus Fund III, L.P.(CIK 1883840)在 11 家公司共报告 110 笔 SEC Form 4 内部人交易(最近一笔 2026-11-18)。

日期公司身份类型股数市值
2026-11-18SpyGlass Pharma, Inc. (SGP)董事买入1,000$32,430
2026-11-03Bambusa Therapeutics, Inc. (BBTX)董事买入189,909$2.7M
2026-11-03Bambusa Therapeutics, Inc. (BBTX)董事买入263,911$3.9M
2026-11-03Bambusa Therapeutics, Inc. (BBTX)董事买入3.1M$0
2026-11-03Bambusa Therapeutics, Inc. (BBTX)董事买入1.3M$0
2026-11-03Bambusa Therapeutics, Inc. (BBTX)董事买入2.3M$37.4M
2026-11-03Bambusa Therapeutics, Inc. (BBTX)董事买入164,891$2.6M
2026-09-30Climb Bio, Inc. (CLYM)董事买入10,000$78,900
2026-09-30Climb Bio, Inc. (CLYM)董事买入10,000$30,000
2026-09-30Climb Bio, Inc. (CLYM)董事买入10,000$34,600
2026-09-30Climb Bio, Inc. (CLYM)董事买入40,000$51,600
2026-09-21Sionna Therapeutics, Inc. (SION)董事卖出3.4M$21.6M
2026-09-21Sionna Therapeutics, Inc. (SION)董事卖出33,800$252,148
2026-08-14Septerna, Inc. (SEPN)董事卖出746,500$31.7M
2026-08-14Septerna, Inc. (SEPN)董事卖出746,500$31.7M
2026-07-31Artiva Biotherapeutics, Inc. (ARTV)董事买入20,824$208,032
2026-07-31Artiva Biotherapeutics, Inc. (ARTV)董事买入24,944$247,694
2026-07-28Artiva Biotherapeutics, Inc. (ARTV)董事买入41,319$412,777
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入6,522$58,307
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入120,582$1.2M
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入84,124$835,351
2026-07-23Artiva Biotherapeutics, Inc. (ARTV)董事买入59,880$596,405
2026-07-22Parabilis Medicines, Inc. (PBLS)董事买入21,696$606,620
2026-07-22Parabilis Medicines, Inc. (PBLS)董事买入98,433$2.7M
2026-07-22Parabilis Medicines, Inc. (PBLS)董事买入32,987$914,400

来源:SEC Form 4 申报文件 · 截至 2026-11-18